Vanda Pharmaceuticals Inc.
Leadership moves, last update 5 months ago
Pharma biotech · Headquarters United States
Everything we hold on Vanda Pharmaceuticals Inc., newest first. Every line links to the filing or report it came from.
- 2026-04-02Headcount Not Stated Leadership moves
Vanda Pharmaceuticals Inc. 8-K filing (Item 5.02): officer or director change
Vanda Pharmaceuticals' general counsel resigns in Washington; the filing does not name a successor.
- 2026-02-19Pay Change Leadership moves
Vanda Pharmaceuticals Inc. 8-K filing (Item 5.02): officer or director change
Executive compensation at Vanda Pharmaceuticals in Washington shifts with new bonuses and salary approvals.
- 2025-12-31Pay Change Pay and benefits
Vanda Pharmaceuticals Inc.: $3,851,468 total compensation for the principal executive officer, fiscal year ended 2025-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2024-12-31Pay Change Pay and benefits
Vanda Pharmaceuticals Inc.: $3,896,241 total compensation for the principal executive officer, fiscal year ended 2024-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2023-12-31Pay Change Pay and benefits
Vanda Pharmaceuticals Inc.: $3,720,215 total compensation for the principal executive officer, fiscal year ended 2023-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
- 2022-12-31Pay Change Pay and benefits
Vanda Pharmaceuticals Inc.: $4,269,410 total compensation for the principal executive officer, fiscal year ended 2022-12-31
Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.
Vanda Pharmaceuticals Inc.. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 20, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/vanda-pharmaceuticals/ Licensed CC BY 4.0; every record links to the document behind it.The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker